West Pharmaceutical Services Inc Net Income per Employee (WST), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


West Pharmaceutical Services Inc   (NYSE: WST)
 

West Pharmaceutical Services Inc Net Income per Employee

WST's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 16.84% in the second quarter 2026, year on year to cumulative value of $565 million, and with 10,800 employees, West Pharmaceutical Services Inc 's income per employee grew on trailing twelve month basis to $ 52,306. The income per employee at West Pharmaceutical Services Inc ' was above the company average.
The Healthcare sector has seen employees of 29 other companies achieving higher income per employee. While West Pharmaceutical Services Inc 's total ranking has deteriorated compared to the previous quarter from 1349 to 1355.


What is Income per Employee Ratio?






WST Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change 16.84 % 54.57 % 1.54 % 2.94 % 18.42 %
Net Income per Employee (TTM) $ 52,306 50,250 45,713 45,528 45,157
WST's Total Ranking # 1355 # 1349 # 369 # 1321 # 1214
Seq. Net Income Change 10.95 % 5.07 % -5.64 % 6.22 % 46.77 %


WST Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 30
Healthcare Sector # 122
Overall Market # 1355

Net Income per Employee Statistics
High Average Low
$ 63,481 $ 29,873 $ 5,796
(Jun 30 2022)   (Sep 30 2011)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Dexcom Inc   90,216.22 $ 1,001.400  Million 11,100 
Globus Medical Inc   89,238.50 $ 535.431  Million 6,000 
Protalix Biotherapeutics inc   83,827.43 $ 18.945  Million 226 
Agilent Technologies inc   79,558.01 $ 1,440.000  Million 18,100 
Alpha Pro Tech Ltd   79,325.20 $ 9.757  Million 123 
Medpace Holdings Inc   79,274.19 $ 491.500  Million 6,200 
Aveanna Healthcare Holdings Inc   78,503.43 $ 274.762  Million 3,500 
Corcept Therapeutics Inc  74,261.64 $ 54.211  Million 730 
Solventum Corporation  71,700.00 $ 1,434.000  Million 20,000 
Insulet Corporation  69,500.00 $ 375.300  Million 5,400 
Strata Critical Medical Inc   66,923.46 $ 40.221  Million 601 
Stryker Corp  66,589.29 $ 3,729.000  Million 56,000 
Pro dex Inc   66,320.39 $ 13.662  Million 206 
Bioventus Inc   65,398.94 $ 61.475  Million 940 
Edwards Lifesciences Corporation  62,725.00 $ 1,003.600  Million 16,000 
Boston Scientific Corporation  62,186.44 $ 3,669.000  Million 59,000 
Vericel Corporation  60,856.78 $ 24.221  Million 398 
Bio techne Corp  60,620.67 $ 181.862  Million 3,000 
Msa Safety Inc  59,246.98 $ 314.009  Million 5,300 
Pfizer Inc  58,266.67 $ 4,370.000  Million 75,000 
Sbc Medical Group Holdings Incorporated  57,479.19 $ 49.605  Million 863 
Electromed Inc   57,365.48 $ 11.301  Million 197 
Utah Medical Products Inc  57,300.55 $ 10.486  Million 183 
Livanova Plc  57,137.27 $ 188.553  Million 3,300 
Medtronic Plc  55,463.16 $ 5,269.000  Million 95,000 
Beone Medicines Ltd   54,642.25 $ 655.707  Million 12,000 
Mettler toledo International Inc   54,554.88 $ 905.611  Million 16,600 
Sotera Health Company  54,493.00 $ 163.479  Million 3,000 
West Pharmaceutical Services Inc   52,305.56 $ 564.900  Million 10,800 
3m Company  49,785.12 $ 3,012.000  Million 60,500 


Date modified: 2026-07-24T15:19:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.